Literature DB >> 31555998

Deep learning for World Health Organization grades of pancreatic neuroendocrine tumors on contrast-enhanced magnetic resonance images: a preliminary study.

Xuan Gao1,2, Xiaolin Wang3,4.   

Abstract

PURPOSE: The World Health Organization (WHO) grading system of pancreatic neuroendocrine tumor (PNET) plays an important role in the clinical decision. The rarity of PNET often negatively affects the radiological application of deep learning algorithms due to the low availability of radiological images. We tried to investigate the feasibility of predicting WHO grades of PNET on contrast-enhanced magnetic resonance (MR) images by deep learning algorithms.
MATERIALS AND METHODS: Ninety-six patients with PNET underwent preoperative contrast-enhanced MR imaging. Fivefold cross-validation was used in which five iterations of training and validation were performed. Within every iteration, on the training set augmented by synthetic images generated from generative adversarial network (GAN), a convolutional neural network (CNN) was trained and its performance was evaluated on the paired internal validation set. Finally, the trained CNNs from cross-validation and their averaged counterpart were separately assessed on another ten patients from a different external validation set.
RESULTS: Averaging the results across the five iterations in the cross-validation, for the CNN model, the average accuracy was 85.13% ± 0.44% and micro-average AUC was 0.9117 ± 0.0053. Evaluated on the external validation set, the average accuracy of the five trained CNNs ranges between 79.08 and 82.35%, and the range of micro-average AUC was between 0.8825 and 0.8932. The average accuracy and micro-average AUC of the averaged CNN were 81.05% and 0.8847, respectively.
CONCLUSION: Synthetic images generated from GAN could be used to alleviate the difficulty of radiological image collection for uncommon disease like PNET. With the help of GAN, the CNN showed the potential to predict the WHO grades of PNET on contrast-enhanced MR images.

Entities:  

Keywords:  Convolutional neural network; Generative adversarial network; Magnetic resonance imaging; Pancreatic neuroendocrine tumor

Mesh:

Substances:

Year:  2019        PMID: 31555998     DOI: 10.1007/s11548-019-02070-5

Source DB:  PubMed          Journal:  Int J Comput Assist Radiol Surg        ISSN: 1861-6410            Impact factor:   2.924


  20 in total

1.  Deep Learning at Chest Radiography: Automated Classification of Pulmonary Tuberculosis by Using Convolutional Neural Networks.

Authors:  Paras Lakhani; Baskaran Sundaram
Journal:  Radiology       Date:  2017-04-24       Impact factor: 11.105

2.  Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor.

Authors:  Rossella Bettini; Stefano Partelli; Letizia Boninsegna; Paola Capelli; Stefano Crippa; Paolo Pederzoli; Aldo Scarpa; Massimo Falconi
Journal:  Surgery       Date:  2011-07       Impact factor: 3.982

3.  Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumours.

Authors:  Carla Cappelli; Ugo Boggi; Salvatore Mazzeo; Rosa Cervelli; Daniela Campani; Niccola Funel; Benedetta Pontillo Contillo; Carlo Bartolozzi
Journal:  Eur Radiol       Date:  2014-12-02       Impact factor: 5.315

4.  Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors?

Authors:  Riccardo De Robertis; Bogdan Maris; Nicolò Cardobi; Paolo Tinazzi Martini; Stefano Gobbo; Paola Capelli; Silvia Ortolani; Sara Cingarlini; Salvatore Paiella; Luca Landoni; Giovanni Butturini; Paolo Regi; Aldo Scarpa; Giampaolo Tortora; Mirko D'Onofrio
Journal:  Eur Radiol       Date:  2018-01-19       Impact factor: 5.315

Review 5.  The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems.

Authors:  David S Klimstra; Irvin R Modlin; Domenico Coppola; Ricardo V Lloyd; Saul Suster
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

6.  Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging.

Authors:  Emad Lotfalizadeh; Maxime Ronot; Mathilde Wagner; Jérôme Cros; Anne Couvelard; Marie-Pierre Vullierme; Wassim Allaham; Olivia Hentic; Philippe Ruzniewski; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2016-08-19       Impact factor: 5.315

7.  Deep Learning with Convolutional Neural Network for Differentiation of Liver Masses at Dynamic Contrast-enhanced CT: A Preliminary Study.

Authors:  Koichiro Yasaka; Hiroyuki Akai; Osamu Abe; Shigeru Kiryu
Journal:  Radiology       Date:  2017-10-23       Impact factor: 11.105

8.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).

Authors:  John K Ramage; A Ahmed; J Ardill; N Bax; D J Breen; M E Caplin; P Corrie; J Davar; A H Davies; V Lewington; T Meyer; J Newell-Price; G Poston; N Reed; A Rockall; W Steward; R V Thakker; C Toubanakis; J Valle; C Verbeke; A B Grossman
Journal:  Gut       Date:  2011-11-03       Impact factor: 23.059

9.  Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage.

Authors:  Riccardo De Robertis; Sara Cingarlini; Paolo Tinazzi Martini; Silvia Ortolani; Giovanni Butturini; Luca Landoni; Paolo Regi; Roberto Girelli; Paola Capelli; Stefano Gobbo; Giampaolo Tortora; Aldo Scarpa; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2017-01-14       Impact factor: 5.742

10.  CNN-SVM for Microvascular Morphological Type Recognition with Data Augmentation.

Authors:  Di-Xiu Xue; Rong Zhang; Hui Feng; Ya-Lei Wang
Journal:  J Med Biol Eng       Date:  2016-12-10       Impact factor: 1.553

View more
  11 in total

1.  Magnetic resonance imaging radiomic analysis can preoperatively predict G1 and G2/3 grades in patients with NF-pNETs.

Authors:  Yun Bian; Jing Li; Kai Cao; Xu Fang; Hui Jiang; Chao Ma; Gang Jin; Jianping Lu; Li Wang
Journal:  Abdom Radiol (NY)       Date:  2020-08-17

2.  Noncontrast Radiomics Approach for Predicting Grades of Nonfunctional Pancreatic Neuroendocrine Tumors.

Authors:  Yun Bian; Zengrui Zhao; Hui Jiang; Xu Fang; Jing Li; Kai Cao; Chao Ma; Shiwei Guo; Li Wang; Gang Jin; Jianping Lu; Jun Xu
Journal:  J Magn Reson Imaging       Date:  2020-04-28       Impact factor: 4.813

Review 3.  GEP-NET radiomics: a systematic review and radiomics quality score assessment.

Authors:  Femke C R Staal; Else A Aalbersberg; Daphne van der Velden; Erica A Wilthagen; Margot E T Tesselaar; Regina G H Beets-Tan; Monique Maas
Journal:  Eur Radiol       Date:  2022-07-26       Impact factor: 7.034

Review 4.  Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations.

Authors:  Gabriel Benyomo Mpilla; Philip Agop Philip; Bassel El-Rayes; Asfar Sohail Azmi
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742

Review 5.  Artificial intelligence for the management of pancreatic diseases.

Authors:  Myrte Gorris; Sanne A Hoogenboom; Michael B Wallace; Jeanin E van Hooft
Journal:  Dig Endosc       Date:  2020-12-05       Impact factor: 7.559

6.  Predicting the recurrence risk of pancreatic neuroendocrine neoplasms after radical resection using deep learning radiomics with preoperative computed tomography images.

Authors:  Chenyu Song; Mingyu Wang; Yanji Luo; Jie Chen; Zhenpeng Peng; Yangdi Wang; Hongyuan Zhang; Zi-Ping Li; Jingxian Shen; Bingsheng Huang; Shi-Ting Feng
Journal:  Ann Transl Med       Date:  2021-05

Review 7.  Machine intelligence in non-invasive endocrine cancer diagnostics.

Authors:  Nicole M Thomasian; Ihab R Kamel; Harrison X Bai
Journal:  Nat Rev Endocrinol       Date:  2021-11-09       Impact factor: 43.330

Review 8.  Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications.

Authors:  Kiersten Preuss; Nate Thach; Xiaoying Liang; Michael Baine; Justin Chen; Chi Zhang; Huijing Du; Hongfeng Yu; Chi Lin; Michael A Hollingsworth; Dandan Zheng
Journal:  Cancers (Basel)       Date:  2022-03-24       Impact factor: 6.639

Review 9.  Artificial Intelligence and Machine Learning in the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms-A Scoping Review.

Authors:  Athanasios G Pantelis; Panagiota A Panagopoulou; Dimitris P Lapatsanis
Journal:  Diagnostics (Basel)       Date:  2022-03-31

10.  Application of CT-Based Radiomics in Discriminating Pancreatic Cystadenomas From Pancreatic Neuroendocrine Tumors Using Machine Learning Methods.

Authors:  Xuejiao Han; Jing Yang; Jingwen Luo; Pengan Chen; Zilong Zhang; Aqu Alu; Yinan Xiao; Xuelei Ma
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.